This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
protein
product name :
Human IGFBP2 / IGF-BP53 Protein (Recombinant) - LS-G4954
catalog :
LS-G4954
product information
ProteinId :
4954
CatalogNumber :
LS-G4954
Product Name :
Human IGFBP2 / IGF-BP53 Protein (Recombinant) - LS-G4954
PresentationDesc :
Lyophilized from PBS, pH 7.2
ProteinType :
Recombinant
ProteinSpecies :
Human
ProteinSourceSpecies :
Trichoplusia ni
RecommendedStorage :
Store at -20°C. Avoid freeze-thaw cycles.
ReconstitutionInstructions :
Centrifuge the vial before opening. Reconstitute in water to 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week.
Purification :
Greater than 98% by SDS-PAGE
PredictedMolecularWeight :
31.5 kDa
Gene :
IGFBP2 / IGF-BP53
StandardGeneSymbol :
IGFBP2
Synonyms :
IGFBP2, BP2, IGFBP-2, IGF-binding protein 2, IBP-2, IBP2, IGF-BP53
ShippingInstruction :
+4°C Ice Packs
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.
questions and comments